Business Overview

Sanamedi advances medical innovation through the medical device business.
Our unique model focuses on creating and scaling new ventures.
By combining consulting, in-house development, investment, and venture building,
we drive value creation in healthcare.
We view business as the integration of multiple processes,
where any missing element can undermine success.
Our strength is in ensuring seamless execution across the entire value chain—
from concept and development to commercialization and growth.

Beyond medical devices and digital health, we span drug discovery and regenerative medicine,
translating technologies and ideas into real businesses.
By leveraging our accumulated knowledge, experience, talent,
and execution capabilities, we increase the probability of successful realization.

SERVICE

We have 4 services

In-house development

Research and Development
Collaboration with industry / academia / municipalities
Manufacturing and distribution of medical devices
Distribution of medical devices
Investment

Investment
Capitalization strategies
Procurement of funds
Hands-on commercialization support
Consulting

Japan / overseas regulatory affairs strategies
Japan / overseas insurance reimbursement strategies
Intellectual property strategies
Business plan design
Overseas expansion
Joint development/industry-academia collaboration
Company creation

Business Concept Design
Opportunity Creation
Capital Policy
Company Establishment
Business Operations

In-house development
We research, develop, and sell medical devices in Japan and overseas.
We will also expand overseas opportunities for other companies’ products.

License in Japan：First class medical devices marketing license(Permission number 13B1X10274）, Sales and rental of highly controlled medical devices(Permission number 5502155221）
License in USA(FDA): Registration Number 3010805418
License in Europe(Authorised Representative)： MedNet EC-REP GmbH
For more information,
please click here.
*Currently, in-house development is limited to medical devices only.

Investment
We will invest in medical startups. We also invest in relatively early-stage companies. However, since Sanamedi is not a venture capital company, we prioritize investment in projects that are expected to have synergistic effects with Sanamedi’s business.

For more information,
please click here.

Consulting
With a focus on overseas expansion, we provide a variety of services such as regulatory strategy and support for the commercialization of medical innovation. In particular, we are good at working with the FDA in areas such as 510(k) applications and in cooperation with local subsidiaries and consultants in USA, and have supported many companies so far. Please feel free to contact us for a quote. For expenses, we also have the choices of stocks or stock options.
Consulting includes joint development and joint business.
We are also actively involved in industry-academia collaboration and collaboration with local governments.

Company creation
We leverage Sanamedi’s accumulated experience and capabilities to create new businesses from the ground up. We participate as a co-founder from the initial concept stage and execute everything in an integrated manner—from business planning and development to fundraising, organizational building, and operations. As a member of the startup team, we commit to day-to-day execution, working together to bring the venture to life and achieve a successful exit.

BUSINESS MODEL

Company Creation Model

In Japan, startups have long been considered difficult to succeed.
We believe a key factor is the lack of true “0→1” capability.
This is not about generating new ideas, but about the ability to define and
execute a winning path—from development to commercialization and exit.
For more than a decade, Sanamedi has focused on building this capability.

Practical Insight &
Strategic Execution

Through three core pillars—in-house development, investment, and consulting—we have cultivated the following capabilities.
Intelligence (Fuel)　
Practical insight including knowledge, experience, regulatory understanding, development know-how, and the ability to assess opportunities
Resilience (Engine)　
The ability to execute and sustain business operations from development to exit

Create new businesses
from scratch in-house and
launch startups

We are pioneering a new model: building ventures from the ground up internally
before launching them as startups.

Beyond development, we rapidly execute the key elements required for commercialization in parallel――
including business planning, fundraising, partnership design, and organizational setup.
By increasing the speed of both decision-making and execution, we drive momentum in business development.
This model enables us to continuously deliver high-probability ventures to market.